MAPT and Alzheimer disease: The SUVR values in regions of expected tau pathology are lower than those reported in Alzheimer’s disease [61], but at a group level higher than those observed in β-amyloid negative normal controls, and can be distinguished qualitatively based on regional uptake patterns.